Company Filing History:
Years Active: 2004-2006
Title: Yong-Moon Choi: Innovator in Central Nervous System Treatments
Introduction
Yong-Moon Choi is a notable inventor based in Towaco, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating central nervous system diseases. With a total of 3 patents, his work has garnered attention for its potential therapeutic applications.
Latest Patents
Yong-Moon Choi's latest patents include innovative compounds that show promise in medical treatments. One of his notable inventions is related to phenylalkyl diamine and amide analogs. This invention pertains to novel 1,2- or 1,3-diamine and amide compounds, which have high binding affinity to the sigma receptor and are useful in treating central nervous system diseases. Another significant patent involves carbamates of 2-heterocyclic-1,2-ethanediols. These carbamate compounds are effective in treating disorders of the central nervous system, particularly as anti-convulsive or anti-epileptic agents.
Career Highlights
Throughout his career, Yong-Moon Choi has worked with prominent companies such as SK Corporation and SK Holdings Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Yong-Moon Choi has collaborated with notable colleagues, including Yong-Kil Kim and Chun-Eung Park. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Yong-Moon Choi's contributions to the development of compounds for treating central nervous system diseases highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical science and providing new treatment options.